“Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study,” by Jorge Cortes, Eric Feldman, Karen Yee, David Rizzieri, Anjali S. Advani, Anthony Charman, Richard Spruyt, Martin Toal, and Hagop Kantarjian (Vol. 14, No. 4, April 2013, p. 354-362).
www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2813%2970037-8/abstract
